Anterix (ATEX)
NasdaqMarket Closed
Anterix Inc. is a US communications company focused on private wireless broadband networks for critical infrastructure operators. The company’s strategy is built around its licensed 900 MHz spectrum holdings, which are designed to support private LTE networks for electric utilities and other industrial customers that need secure, resilient, and dedicated connectivity.
For utilities, Anterix positions private LTE as a foundation for grid modernization. The technology can connect substations, field devices, sensors, distributed energy resources, workers, and operational systems across wide service territories. This connectivity can help utilities improve outage response, automate grid functions, monitor equipment and environmental conditions, and support the growing data demands created by renewable energy integration and electrification.
The company does not operate like a traditional consumer mobile carrier. Instead, it works with utilities, technology vendors, and infrastructure partners to enable purpose-built networks controlled by enterprise customers. Its spectrum is particularly relevant to organizations that require predictable performance, long asset lives, cybersecurity controls, and communications that remain available during storms, wildfires, or other emergencies.
Anterix’s market opportunity is tied to long-term investment in smarter energy and industrial infrastructure. As utilities replace aging communications systems and seek alternatives to public networks, private broadband can become a strategic asset. The company’s role is to provide the licensed spectrum and ecosystem support needed to make those networks viable at scale.
Last updated
- Market Cap
- $1,672,910,844
- P/E
- 25.46
- P/FCF
- 157.39
- P/S
- 237.6
- Enterprise Value
- $1,556,900,844
- Sector
- Communication Services
- Industry
- Integrated Telecommunication Services
- Address
- 3 GARRET MOUNTAIN PLAZA, WOODLAND PARK, NJ, 07424
Anterix Sees Scarce 900 MHz Spectrum Driving Utility Deals and Satellite Upside
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Boston Scientific, Clorox, CrowdStrike, Exxon Mobil, Honeywell International, Intuit, Intuitive Surgical, Levi Strauss, and More
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- $1,672,910,844
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- $1,556,900,844
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 25.46
- P/B
P/B ratio compares a company's share price to its book value per share.
- 5.85
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 237.6
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -38.62
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 221.12
- EPS
- 3.35
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 157.39
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 156.41
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- $10,629,000
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 22.99%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 13.19%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 4.85
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 4.85
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 3.68
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- $352,244
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 85.31
Income Statement
| Line Item | 2027 Q1 | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 |
|---|---|---|---|---|---|
| Revenue | 1.96M | 1.96M | 1.57M | 1.55M | 1.42M |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 |
| Gross profit | 1.96M | 1.96M | 1.57M | 1.55M | 1.42M |
| Operating income | -10.9M | -13.27M | -10.2M | -10.38M | -12.39M |
| EBITDA | -10.8M | -10.39M | -9.63M | -9.51M | -11.64M |
| Net income | 240K | 18.52M | -6.6M | 53.54M | 25.18M |
| Income taxes | 374K | 1.86M | -2.05M | 7.52M | -2.26M |
| Interest expense | 0 | 0 | 0 | 0 | 0 |
| Other operating expenses | 0 | 2.78M | 465K | 735K | 620K |
| Total operating expenses | 12.86M | 15.23M | 11.77M | 11.93M | 13.81M |
| Basic EPS | 0.01 | 0.99 | -0.35 | 2.86 | 1.35 |
| Diluted EPS | 0.01 | 0.98 | -0.35 | 2.86 | 1.35 |
Balance Sheet
| Line Item | 2027 Q1 | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 |
|---|---|---|---|---|---|
| Total assets | 497.93M | 465.21M | 417M | 420.38M | 359.58M |
| Total liabilities | 212.13M | 202.89M | 181.05M | 180.03M | 174.81M |
| Total equity | 285.79M | 262.32M | 235.95M | 240.35M | 184.77M |
| Cash & equivalents | 116.01M | 98.53M | 29.53M | 39.07M | 41.43M |
| Current assets | 153.08M | 119.99M | 50.06M | 58.8M | 55.36M |
| Current liabilities | 31.55M | 36M | 36.02M | 34.62M | 35.95M |
| Accounts payable | 11.92M | 15.03M | 14.89M | 14.82M | 6.62M |
| Receivables | 14.27M | 10.64M | 8.7M | 7.55M | 5.33M |
| Inventories | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
Cash Flow
| Line Item | 2027 Q1 | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 2.05M | 15.52M | -8.27M | 1.4M | -3.14M |
| Investing cash flow | -6.74M | 46.1M | -2.3M | -604K | -2.67M |
| Financing cash flow | 19.95M | 5.15M | -10K | -907K | -642K |
| Change in cash | 15.26M | 66.78M | -10.58M | -107K | -6.45M |
| Net income | 240K | 18.52M | -6.6M | 53.54M | 25.18M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | S-8 — Anterix Inc. | View Filing | |
| edgar index | 4 — Anterix Inc. | View Filing | |
| form 4 | Form 4 — Heard William | View Filing | |
| form 4 | Form 4 — Heard William | View Filing | |
| edgar index | 4 — Anterix Inc. | View Filing | |
| edgar index | 4 — Anterix Inc. | View Filing | |
| edgar index | 4/A — Anterix Inc. | View Filing | |
| edgar index | 144 — Anterix Inc. | View Filing | |
| form 4 | Form 4 — Lang Scott A. | View Filing | |
| form 4 | Form 4 — Lang Scott A. | View Filing | |
| form 4 | Form 4 — Lang Scott A. | View Filing | |
| form 4 | Form 4 — Lang Scott A. | View Filing | |
| form 4 | Form 4 — Heard William | View Filing | |
| form 4 | Form 4 — Heard William | View Filing | |
| edgar index | 8-K — Anterix Inc. | View Filing | |
| edgar index | 10-Q — Anterix Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Anterix Inc. | View Filing | |
| edgar index | 4 — Anterix Inc. | View Filing | |
| edgar index | 4 — Anterix Inc. | View Filing | |
| edgar index | 4 — Anterix Inc. | View Filing | |
| edgar index | 8-K — Anterix Inc. | View Filing | |
| edgar index | 4 — Anterix Inc. | View Filing | |
| edgar index | 4 — Anterix Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Owl Creek Asset Management, L.P. | View Filing | |
| form 4 | Form 4 — ALTMAN JEFFREY A | View Filing | |
| form 4 | Form 4 — ALTMAN JEFFREY A | View Filing | |
| form 4 | Form 4 — Owl Creek Asset Management, L.P. | View Filing | |
| form 4 | Form 4 — Owl Creek Asset Management, L.P. | View Filing | |
| form 4 | Form 4 — ALTMAN JEFFREY A | View Filing | |
| form 4 | Form 4 — DANIELS LESLIE B | View Filing | |
| form 4 | Form 4 — DANIELS LESLIE B | View Filing | |
| form 4 | Form 4 — DANIELS LESLIE B | View Filing | |
| form 4 | Form 4 — YAZDI MAHVASH | View Filing | |
| form 4 | Form 4 — YAZDI MAHVASH | View Filing | |
| form 4 | Form 4 — YAZDI MAHVASH | View Filing | |
| form 4 | Form 4 — Heard William | View Filing | |
| form 4 | Form 4 — Heard William | View Filing | |
| form 4 | Form 4 — Fleischhauer Mark | View Filing | |
| edgar index | SCHEDULE 13G — Anterix Inc. | View Filing | |
| edgar index | DEFA14A — Anterix Inc. | View Filing | |
| edgar index | 4 — Anterix Inc. | View Filing | |
| edgar index | 4 — Anterix Inc. | View Filing | |
| form 4 | Form 4 — Guttman-McCabe Christopher | View Filing | |
| form 4 | Form 4 — Marquez Elena | View Filing | |
| edgar index | 4/A — Anterix Inc. | View Filing | |
| edgar index | SCHEDULE 13D/A — Anterix Inc. | View Filing | |
| edgar index | SCHEDULE 13G — Anterix Inc. | View Filing | |
| edgar index | 3 — Anterix Inc. | View Filing | |
| form 3 | Form 3 — Kerr Kimberly | View Filing | |
| form 3 | Form 3 — Kerr Kimberly | View Filing | |
| edgar index | 10-K — Anterix Inc. | View Filing | |
| edgar index | DEF 14A — Anterix Inc. | View Filing | |
| edgar index | ARS — Anterix Inc. | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 4 — Anterix Inc. | View Filing | |
| edgar index | 4 — Anterix Inc. | View Filing | |
| form 4 | Form 4 — Lang Scott A. | View Filing | |
| edgar index | 4 — Anterix Inc. | View Filing | |
| edgar index | 4 — Anterix Inc. | View Filing | |
| edgar index | 4 — Anterix Inc. | View Filing | |
| edgar index | 4 — Anterix Inc. | View Filing | |
| edgar index | 144 — Anterix Inc. | View Filing | |
| edgar index | 4 — Anterix Inc. | View Filing | |
| form 4 | Form 4 — Marquez Elena | View Filing | |
| form 4 | Form 4 — Marquez Elena | View Filing | |
| form 4 | Form 4 — Marquez Elena | View Filing | |
| edgar index | 144 — Anterix Inc. | View Filing | |
| form 4 | Form 4 — YAZDI MAHVASH | View Filing | |
| form 4 | Form 4 — YAZDI MAHVASH | View Filing | |
| form 4 | Form 4 — YAZDI MAHVASH | View Filing | |
| edgar index | 144 — Anterix Inc. | View Filing |